MENU
AGIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Agios Pharmaceuticals (AGIO) Ownership - Who owns Agios Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.39B
P/E Ratio
3.60
Total Cash
1B
Projected Growth
N/A
Total Debt
60.83M
Revenue
32.87M
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash/Share
17.62
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
AGIO
Capitalization
2.39B
P/E Ratio
3.60
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash
1.01B
Total Cash/Share
17.62
Total Debt
60.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
32.9M
ROE
N/A
Book Value
1.63B
P/B Ratio
1.47
Cash Flow
N/A
Earnings
11.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73K
Current Ratio
8.99
Current Revenue Per Employee
23222.80
Dividends Per Share - Security
N/A
EBITDA
-401.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.27
Revenue To Assets
48.18
Shares Held By Institutions
5.75B
Shares Outstanding - Current
57M
Total Liabilities
165M
Total Volume MTD
N/A
Value
N/A
Gain YTD
88.415
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com